BL Pharmtech Corp. (KOSDAQ:065170)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,990.00
+53.00 (2.74%)
At close: Aug 24, 2026

BL Pharmtech Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6,6557,1513,86410,6075,02421,752
Short-Term Investments
00-2,6005001,000
Cash & Short-Term Investments
6,6557,1513,86413,2075,52422,752
Cash Growth
83.74%85.08%-70.74%139.10%-75.72%83.78%
Accounts Receivable
1,476762.27857.11,0119,20810,364
Other Receivables
26.1442.68126.4972.821,863120.06
Receivables
1,633836.15983.61,08311,07111,097
Inventory
474.52510.571,6331,89314,7547,765
Prepaid Expenses
12.8511.82116.73213.11353.3760.02
Other Current Assets
77.1673.73340.05518.21909.22627.19
Total Current Assets
8,8528,5846,93716,91532,61242,301
Property, Plant & Equipment
3,7203,8084,1292,87842,33942,899
Long-Term Investments
5,1874,78813,88422,05617,01126,439
Goodwill
--0-0-8,00013,151
Other Intangible Assets
71.1775.87221.15548.991,1701,538
Long-Term Accounts Receivable
-45.31151.090--
Long-Term Deferred Tax Assets
----1,5321,679
Long-Term Deferred Charges
-----3.94
Other Long-Term Assets
806.6791.4211,0312,4031,0232,330
Total Assets
18,74118,19536,45844,802103,687130,341

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
389.44314.52402.831,0782,8457,254
Accrued Expenses
91.3291.653.5462.56555.77447.08
Short-Term Debt
3,0513,1723,875-29,0927,817
Current Portion of Long-Term Debt
-1,300-1,4101,96712,804
Current Portion of Leases
467.01448.34390.6361.19504.13422.67
Other Current Liabilities
3,2103,6671,9075,05414,0158,255
Total Current Liabilities
7,2098,9946,6297,96548,97937,000
Long-Term Debt
--1,3002,34310,73920,694
Long-Term Leases
3.05121.34534.77148.36404156.55
Pension & Post-Retirement Benefits
828.21784.29609.93507.072,0882,770
Long-Term Deferred Tax Liabilities
250.17250.17202.8252.17310.39360
Other Long-Term Liabilities
123.29117.952,9141,78784.293,852
Total Liabilities
8,41310,26812,19013,00262,60464,832

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
13,95713,3424,44944,48544,48544,485
Additional Paid-In Capital
95,08793,713102,524101,17599,995100,007
Retained Earnings
-99,678-100,206-68,625-102,983-95,790-82,200
Treasury Stock
-9.35-9.35-1.69-1.69-1.69-1.69
Comprehensive Income & Other
942.571,057-14,099-11,257-14,888-3,794
Total Common Equity
10,2997,89624,24731,41933,80058,497
Minority Interest
28.1831.721.56380.357,2827,013
Shareholders' Equity
10,3277,92724,26831,79941,08265,510
Total Liabilities & Equity
18,74118,19536,45844,802103,687130,341

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3,5215,0426,1004,26242,70641,894
Net Cash (Debt)
3,1342,110-2,2368,945-37,182-19,142
Net Cash Growth
------
Net Cash Per Share
117.3079.07-83.85335.15-1393.08-726.73
Filing Date Shares Outstanding
27.9126.688.8926.6926.6926.69
Total Common Shares Outstanding
27.9126.682.6726.6926.6926.69
Working Capital
1,644-410.36308.538,951-16,3675,301
Book Value Per Share
369.01295.959088.311177.161266.372191.67
Tangible Book Value
10,2287,82024,02530,87024,63043,807
Tangible Book Value Per Share
366.46293.119005.411156.59922.801641.29
Land
-2,5382,5381,8129,5539,553
Buildings
-2,2972,2971,87721,72621,726
Machinery
-402.84402.84396.0416,83515,761
Construction In Progress
-----32.85